Seminars in Pediatric Neurology
Volume 15, Issue 1 , Pages 2-9 , March 2008

Genetic Evaluation of Intellectual Disabilities

  • John B. Moeschler, MD, MS

      Affiliations

    • Corresponding Author InformationAddress reprint requests to John B. Moeschler, MD, MS, Dartmouth-Hitchcock Medical Center, Medical Genetics, One Medical Center Drive, Lebanon, NH 03756.

References 

  1. Shevell MI. The evaluation of the child with a global developmental delay. Semin Pediatr Neurol. 1998;5:21–26
  2. Cassel E. The nature of suffering and the goals of medicine. N Engl J Med. 1982;306:639–645
  3. Rosenbaum P. Prevention of psychosocial problems in children with chronic illness. Can Med Assoc J. 1988;139:293–295
  4. Cassidy SB, Allenson JE. Management of Genetic Syndromes. Hoboken, NJ: Wiley-Liss; 2005;
  5. Accardo P, Capute A. Intellectual disability. In:  Oski F,  Deangelis CD editor. Principles and Practice of Pediatrics. Philadelphia, PA: Lippincott; 1995;p. 673–679
  6. Majnemer A, Shevell M. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr. 1995;127:193–199
  7. Schroeder S, Gerry M, Gert G, et al. Final Project Report: Usage of the term “Intellectual disability:” Language, Image and Public Education., in American Association of Intellectual disability Resource Network International (Center on Developmental Disabilities; Center for the Study of Family, Neighborhood and Community Policy, University of Kansas). In: 2001;p. 1–216
  8. Luckasson R, Borthwick-Duffy S, Buntinx WHE, et al. Intellectual Disability: Definition, Classification, and Systems of Support. 10th ed. Washington, DC: American Association on Intellectual Disability; 1992;
  9. American Association on Intellectual and Developmental Disabilities. http://www.aaidd.orgAccessed November 23, 2007
  10. Shevell M, Ashwal S, Donley D, et al. Practice parameter: Evaluation of the child with global developmental delay—Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60:367–380
  11. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin North Am. 1992;39:929–943
  12. Van Karnebeek CD, Koevoets C, Sluijter S, et al. Prospective screening for subtelomeric rearrangements in children with intellectual disability of unknown aetiology: The Amsterdam experience. J Med Genet. 2002;39:546–553
  13. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: recommendations of a consensus conference—American College of Medical Genetics. Am J Med Genet. 1997;72:468–477
  14. Shevell M, Ashwal S, Donley D, et al. Practice parameter evaluation of the child with global developmental delay—report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60:367–380
  15. Moeschler JB, Shevell MI. AAP Committee on Genetics: Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117:2304–2316
  16. Aase JM. Diagnostic Dysmorphology. In: 3rd ed. New York, NY: Plenum Medical Book Company; 1990;p. 32–34
  17. Marden PM, Smith DW, McDonald MJ. Congenital anomalies in the newborn infant, including minor variations. J Pediatr. 1964;64:357–371
  18. Opitz JM. Invited editorial comment: Study of minor anomalies in childhood malignancy. Eur J Pediatr. 1985;144:252–254
  19. Smith DW, Bostian KE. Congenital anomalies associated with idiopathic intellectual disability. J Pediatr. 1964;65:189–196
  20. Hunter AG. Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am J Med Genet. 2000;90:60–68
  21. Van Karnebeek CDH, Janswiejer MCE, Leenders AGE, et al. Diagnostic investigations in individuals with mental retardation: A systematic literature review of their usefulness. Eur J Human Genet. 2005;13:2–65
  22. Battaglia A, Carey JC. Diagnostic evaluation of developmental delay/mental retardation: an overview. Am J Med Genet C Semin Med Genet. 2003;117:3–14
  23. Shevell MI, Majnemer A, Rosenbaum P, et al. Etiologic yield of subspecialists’ evaluation of young children with global developmental delay. J Pediatr. 2000;136:593–598
  24. Hagberg B, Hagberg G, Lewerth A, et al. Mild mental retardation in Swedish school children (II. Etiologic and pathogenetic aspects). Acta Paediatr Scand. 1981;70:445–452
  25. Stromme P. Aetiology in severe and mild mental retardation: A population-based study of Norwegian children. Dev Med Child Neurol. 2000;42:76–86
  26. McDonald A. Severely retarded children in Quebec: prevalence, causes, and care. Am J Ment Defic. 1973;78:205
  27. Schreppers-Tijdink GA, Curfs LM, Wiegers A, et al. A systematic cytogenetic study of a population of 1170 mentally retarded and/or behaviourally disturbed patients including fragile X-screening (The Hondsberg experience). J Genet Hum. 1988;36:425–426
  28. Knight SJ, Flint J. Perfect endings: A review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000;37:401–409
  29. Biesecker LG. The end of the beginning of chromosome ends. Am J Med Genet. 2002;107:263–266
  30. de Vries BB, White SM, Knight SJ, et al. Clinical studies on submicroscopic subtelomeric rearrangements: A checklist. J Med Genet. 2001;38:145–150
  31. Bejjani BA, Theisen AP, Ballif BC, et al. Array-based comparative genomic hybridization in clinical diagnosis. Expert Rev Mol Diagn. 2005;5:421–429
  32. Shaffer LG, Kashork CD, Saleki R, et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr. 2006;149:98–102
  33. Shaw-Smith C, Redon R, Rickman L, et al. Microarray based comparative genomic hybridization (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/MR and dysmorphic features. J Med Genet. 2004;41:241–248
  34. Vissers LE, de Vries BB, Osoegawa K, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet. 2003;73:1261–1270
  35. Schoumans J, Ruivenkamp C, Holmberg E, et al. Detection of chromosomal imbalances in children with idiopathic MR by array based comparative genomic hybridization idiopathic MR by array based comparative genomic hybridization (array-CGH). J Med Genet. 2005;42:699–705
  36. Tyson C, Harvard C, Loceker R, et al. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet. 2005;139AZ:173–185
  37. de Vries BB, Pfundt R, Leisink M, et al. Diagnostic genome profiling in MR. Am J Hum Genet. 2005;77:606–616
  38. Miyake N, Shimokawa O, Harada N, et al. BAC array-CGH reveals genomic aberrations in idiopathic MR. Am J Med Genet A. 2006;140:205–211
  39. Menten B, Maas N, Thienpont B, et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: A new series of 140 patients and review of published reports. J Med Genet. 2006;43:625–633
  40. Hoyer J, Dreweke A, Beckter C, et al. Molecular karyotyping in patients with mental retardation using 100k single-nucleotide polymorphism arrays. J Med Genet. 2007;44:629–636
  41. Engels H, Brockschmidt A, Hoischen A, et al. DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology. 2007;68:743–750
  42. de Vries BB, van den Ouweland AM, Mohkamsing S, et al. Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey (Collaborative Fragile Study Group). Am J Hum Genet. 1997;61:660–667
  43. de Vries BB, Mohkamsing S, van den Ouweland AM, et al. The Collaborative Fragile Study Group Screening for the fragile X syndrome among the mentally retarded: A clinical study. J Med Genet. 1999;36:467–470
  44. Jiang Y-H, Lev-Lehman E, Tsai T-F, et al. Neurogenetics ’99 Genetics of Angelman syndrome. Am J Hum Genet. 1999;65:1–6
  45. Zoghbi HY. Postnatal neurodevelopmental disorders: Meeting at the synapse. Science. 2003;302:826–830
  46. Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked intellectual disability. Hum Mol Genet. 2001;10:941–946
  47. Moeschler JB, Bennett FC, Cromwell LD. Use of the CT scan in the medical evaluation of the mentally retarded child. J Pediatr. 1981;98:63–65
  48. Lingam S, Read S, Holland IM, et al. Value of computerised tomography in children with non-specific mental subnormality. Arch Dis Child. 1982;57:381–383
  49. Gabrielli O, Salvolini U, Coppa GV, et al. Magnetic resonance imaging in the malformative syndromes with mental retardation. Pediatr Radiol. 1990;21:16–19
  50. Schaefer GB, Bodensteiner JB. Radiological findings in developmental delay. Semin Pediatr Neurol. 1998;36:33–38
  51. Demaerel P, Kingsley DP, Kendall BE. Isolated neurodevelopmental delay in childhood: Clinicoradiological correlation in 170 patients. Pediatr Radiol. 1993;23:29–33
  52. Kjos BO, Umansky R, Barkovich AJ. Brain MR imaging in children with developmental retardation of unknown cause: Results in 76 cases. AJNR Am J Neuroradiol. 1990;11:1035–1040
  53. Bouhadiba Z, Dacher J, Monroc M, et al. MRI of the brain in the evaluation of children with developmental delay. [French] J Radiol. 2000;81:870–873
  54. Harbord MG, Finn JP, Hall-Craggs MA, et al. Myelination patterns on magnetic resonance of children with developmental delay. Dev Med Child Neurol. 1990;32:295–303

PII: S1071-9091(08)00003-X

doi: 10.1016/j.spen.2008.01.002

Seminars in Pediatric Neurology
Volume 15, Issue 1 , Pages 2-9 , March 2008

Article Tools